About SynGen
SynGen is a company based in Sacramento (United States) founded in 2009 was acquired by Cesca Therapeutics in July 2017.. SynGen has raised $16.81 million across 14 funding rounds from investors including GE Capital, Cesca Therapeutics and Bay City Capital. SynGen operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Hemotune, Singulex and Cell Microsystems, among others.
- Headquarter Sacramento, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.81 M (USD)
in 14 rounds
-
Latest Funding Round
$500 K (USD), Series A
Apr 21, 2017
-
Investors
GE Capital
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Cesca Therapeutics
(Jul 07, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SynGen
SynGen has successfully raised a total of $16.81M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series A — $500,000
-
First Round
First Round
(23 Apr 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2017 | Amount | Series A - SynGen | Valuation |
investors |
|
| Mar, 2017 | Amount | Series A - SynGen | Valuation |
investors |
|
| Feb, 2017 | Amount | Series A - SynGen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SynGen
SynGen has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Cesca Therapeutics and Bay City Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Founded Year | Domain | Location | |
|
Commercial aircraft and equipment leasing and lending services are provided.
|
Founded Year | Domain | Location | |
|
Cell-based therapeutics are developed for regenerative medicine applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SynGen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SynGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Syngen Comparisons
Competitors of SynGen
SynGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Hemotune, Singulex and Cell Microsystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops flow cytometry and cell sorting technology
|
|
| domain | founded_year | HQ Location |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| domain | founded_year | HQ Location |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| domain | founded_year | HQ Location |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SynGen
When was SynGen founded?
SynGen was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is SynGen located?
SynGen is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Is SynGen a funded company?
SynGen is a funded company, having raised a total of $16.81M across 14 funding rounds to date. The company's 1st funding round was a Series A of $500K, raised on Apr 23, 2012.
What does SynGen do?
SynGen develops cell separation tools and accessories, applying design to aid regenerative medicine workflows. SynGen design and manufacture products that focus on improving recovery of target cells, depletion of contaminating cells, efficiency and operator ease of use. Also, reduces time for the development of therapeutic products.
Who are the top competitors of SynGen?
SynGen's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Who are SynGen's investors?
SynGen has 3 investors. Key investors include GE Capital, Cesca Therapeutics, and Bay City Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.